We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




US Companies Push to Improve Patient Safety

By HospiMedica staff writers
Posted on 22 Nov 2000
A group of 60 large U.S. More...
companies that collectively insure more than 20 million people is making an effort to reduce medical errors and improve patient safety by encouraging their employees to use hospitals that employ three patient safety measures shown to reduce mistakes. They have agreed to base their purchase of health care on principles promoting these safety measures.

The first safety measure is computerized physician order entry (CPOE), shown to reduce serious prescribing errors in hospitals by more than 50%. The second safety measure is evidence-based hospital referral. Research shows that by referring patients needing complex medical procedures to hospitals offering the best survival odds based on scientifically valid criteria--such as the number of times a hospital performs the procedure each year--a patient's risk of dying could be reduced by more than 30%. The third safety measure is staffing the intensive care unit (ICU) with doctors trained in critical care medicine. Research shows this can reduce the risk of patients dying in the ICU by 10%.

The group of companies, called The Leapfrog Group, includes many major U.S. companies, including General Motors, Textron, GE, IBM, and AT&T. Member companies have all agreed to educate and inform enrollees in their health care plans about patient safety, to reward health care providers for advances in preventing errors, to hold health care plans accountable for implementing the group's purchasing principles, and to build the support of benefits consultants for these principles.

"Coming together with other employers through The Leapfrog Group, we feel confident in our ability to make a difference by harnessing and leveraging our health care purchasing power,” said Lewis. B. Campbell, chairman and CEO of Textron, Inc.

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Syringe Pump
SP50 Series
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible

Basal cell carcinoma is the most common form of skin cancer and can damage nearby structures such as the nose or eyes when it develops on the face. Diagnosis typically depends on visible skin changes,... Read more

Surgical Techniques

view channel
Image: Associate Professor Menglin Chen studies how the light-sensitive nanoparticles affect living cells. The screen shows calcium being released inside a cell after nanoparticles taken up by the cell are exposed to blue light. Calcium plays an important role in cellular signaling, and the experiment helps the researchers understand how the nanoparticles can translate light into biological activity. (Photo courtesy of Aarhus University, Johanne Holm Jensen)

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.